Creating Rare Connections
Leveraging Technology to Bridge the Gap between Patients and Pharma Patient populations for individual rare diseases are usually small and spread out across many geographies…
Pharma
BioSamples – The Block Between Bench and Bedside
A 2018 survey conducted by the UK agency Medicines Discovery Catapult found that 80% of SMEs (small to medium sized biotechs) found accessing biosamples from…
Ending the Global Pandemic Starts with An Adaptable Supply Chain
The development of no less than five separate, highly effective vaccines against COVID-19 in less than a year is nothing short of miraculous. As the…
Digital Technologies: Pharma’s Answer to Achieving Net Zero Emissions?
In June of this year, the Pacific Northwest battled unprecedented “heat domes,” which climate scientists agree would not have occurred in the absence of man-made…
How AI and ML is Driving Value for Global Pharma Players
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…
Leading Clinical Technology Providers Join Forces to Tackle Key Clinical Trial Pain Point
uMotif and Xperiome, a global healthtech company specialising in rare disease are to collaborate through a partnership that will bring value to both life science…
How Rep Relationships Open Digital Doors to HCPs
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
The Business of Biospecimen Procurement needs to be Revised
The journey of a biospecimen used for medical research begins with the donor and ends in a research laboratory. What happens between those two points…
Digital Pharma Manufacturing Revolution In Cases
Top-level management from pharma companies and IT leaders from the manufacturing and packaging sector get together at Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) on…
Four Steps for CROs Embarking on a Permanent Digital Transformation
The events of 2020 changed how the life sciences industry works – possibly forever. Prior to the emergence of COVID-19, some Contract Research Organisations (CROs)…